×
GreekEnglish

×
  • Politics
  • Diaspora
  • World
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Cooking
Thursday
15
Jan 2026
weather symbol
Athens 9°C
  • Home
  • Politics
  • Economy
  • World
  • Diaspora
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Mediterranean Cooking
  • Weather
Contact follow Protothema:
Powered by Cloudevo
> World

Injectable hydrogel fills surgical cavities to keep brain cancer at bay

The survival rates for glioblastoma are among the lowest of any cancer, with less than 5% of patients surviving five years after diagnosis

Newsroom August 10 02:44

Glioblastoma is one of the most deadly forms of cancer, often returning with a vengeance after surgery to remove it. Researchers at the University of Wisconsin-Madison have now developed an immunity-boosting hydrogel that can be injected into the brain after surgery to clear out remaining cancer stem cells.

The survival rates for glioblastoma are among the lowest of any cancer, with less than 5% of patients surviving five years after diagnosis. That’s largely because this brain cancer has a tendency to come back after the tumor is surgically removed, as glioma stem cells are left behind to form new tumors.

See Also:

>Related articles

People over 110 maintain health with an immune system that resists aging

FBI searches the home of a Washington Post journalist who covered the Trump administration’s firing of federal employees

Countdown to a U.S. strike on Iran: Americans and Britons evacuate bases, direct assassination threat against Trump from Tehran – Live

Bizarre study finds common parasite can make you more attractive

“One characteristic of glioblastoma is that the tumor cells are very aggressive, and they will infiltrate the surrounding tissues,” said Quanyin Hu, corresponding author of the study. “So the surgeon can’t clearly feel the boundaries between the tumor and the normal tissue, and you cannot remove as much as possible because all the tissues in the brain are extremely important – you certainly don’t want to remove too much.”

Read more: New Atlas

Ask me anything

Explore related questions

#brain#cancer#cavities#health#hydrogel#medicine#science#technology#world
> More World

Follow en.protothema.gr on Google News and be the first to know all the news

See all the latest News from Greece and the World, the moment they happen, at en.protothema.gr

> Latest Stories

People over 110 maintain health with an immune system that resists aging

January 15, 2026

A flu surge is coming: 100 patients in one day at Evangelismos hospital

January 15, 2026

Greece introduces a legal framework for undercover agents infiltrating criminal groups

January 15, 2026

Trump signals possible fast strike on Iran as U.S. military moves intensify

January 15, 2026

Weather: Alcyonides until Friday with rising temperatures and weakening winds

January 15, 2026

Mitsotakis’ meeting with farmers: Blockades may ease after announced measures

January 15, 2026

Profile of the “businessman” arrested with weapons in Paleo Faliro: A criminal past of extortion, tax evasion, and robbery

January 15, 2026

What a new US operation against Iran would involve: the weapons and possible targets

January 15, 2026
All News

> World

Trump signals possible fast strike on Iran as U.S. military moves intensify

The United States appears to be preparing for possible military action against Iran, as signs of increased military activity continue to emerge in the Middle East

January 15, 2026

What a new US operation against Iran would involve: the weapons and possible targets

January 15, 2026

FBI searches the home of a Washington Post journalist who covered the Trump administration’s firing of federal employees

January 14, 2026

Countdown to a U.S. strike on Iran: Americans and Britons evacuate bases, direct assassination threat against Trump from Tehran – Live

January 14, 2026

Direct assassination threat against Trump from Iran: “This time the bullet will not miss the target”

January 14, 2026
Homepage
PERSONAL DATA PROTECTION POLICY COOKIES POLICY TERM OF USE
Powered by Cloudevo
Copyright © 2026 Πρώτο Θέμα